rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

iRhythm Holdings, Inc.

IRTC · Nasdaq

Health CareMedical DevicesSetting up

IRTC stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 41 weeks. It is 2.2% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 41
Industry in uptrend
29% -5 in 4 wk
Insider buys, 12 months
$114K
Insider sales, 12 months
$53.6M
Officials’ trades on record
1
Institutions holding
288 (+7)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.

21 Apr – 20 Oct
19%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$20.1M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Donna E. Shalala House: U.S. House ClerkFL27sold$1k–$15k24 Jun 2019filed 27 Apr 2020

Insiders

Buy orders, 12 months1
Sale orders, 12 months40
Buyers · sellers1 · 12
WhoDidSharesTraded
Daniel G. WilsonChief Financial Officersold773at $121.832 Sep 2026filed 3 Sep 2026
Quentin S. BlackfordPresident and CEOsold26,859at $124.6510 Aug 2026filed 11 Aug 2026
Patrick Michael MurphyCBO and CLOsold7,093at $124.6510 Aug 2026filed 11 Aug 2026
Chad PattersonCHIEF COMM & PRODUCT OFFICERsold7,093at $124.6510 Aug 2026filed 11 Aug 2026
Sumi ShrishrimalEVP, Chief Risk Officersold5,372at $124.6510 Aug 2026filed 11 Aug 2026
Minang TurakhiaCHIEF MED/SCI OFCR EVP ADVTECHsold7,093at $124.6510 Aug 2026filed 11 Aug 2026
Chad PattersonCHIEF COMM & PRODUCT OFFICERsold2,712at $122.123 Aug 2026filed 4 Aug 2026
Mervin SmithEVP Strategic Business Opssold617at $122.123 Aug 2026filed 4 Aug 2026
Julianne RoddaEVP, CHIEF PEOPLE OFFICERsold2,112at $122.123 Aug 2026filed 4 Aug 2026
Minang TurakhiaCHIEF MED/SCI OFCR EVP ADVTECHsold1,423at $124.712 Jul 2026filed 6 Jul 2026
Sean Clinton FreemanEVP, Strategy & Corp Devtsold918at $124.712 Jul 2026filed 6 Jul 2026
Sumi ShrishrimalEVP, Chief Risk Officersold1,716at $108.192 Jun 2026filed 3 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders288+7 on the quarter
New · exited50 · 42
Reported value$4.2B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20262,985,667$355.1M+244,162+8.9%
RTW INVESTMENTS, LPadded · filed 14 Aug 20262,182,631$259.6M+514,131+30.8%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20261,913,976$227.7M+117,604+6.5%
Artisan Partners Limited Partnershipadded · filed 13 Aug 20261,660,307$197.5M+209,400+14.4%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,463,211$174.0M+17,501+1.2%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 20261,406,454$167.3M-201,560−12.5%
FMR LLCreduced · filed 13 Aug 20261,191,982$141.8M-169,937−12.5%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCreduced · filed 13 Aug 2026944,517$112.4M-102,935−9.8%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026881,899$104.9M+64,789+7.9%
EVENTIDE ASSET MANAGEMENT, LLCadded · filed 14 Aug 2026880,338$104.7M+119,513+15.7%
31 Mar 2023 – 30 Jun 2026
177243308Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Daniel G. Wilson Company insiderChief Financial Officer · last 2 Sep 20260 · 23
Chad Patterson Company insiderCHIEF COMM & PRODUCT OFFICER · last 10 Aug 20261 · 16
Minang Turakhia Company insiderCHIEF MED/SCI OFCR EVP ADVTECH · last 10 Aug 20260 · 10
Patrick Michael Murphy Company insiderCBO and CLO · last 10 Aug 20260 · 12
Quentin S. Blackford Company insiderPresident and CEO · last 10 Aug 20261 · 11
Sumi Shrishrimal Company insiderEVP, Chief Risk Officer · last 10 Aug 20260 · 11
Julianne Rodda Company insiderEVP, CHIEF PEOPLE OFFICER · last 3 Aug 20260 · 1
Mervin Smith Company insiderEVP Strategic Business Ops · last 3 Aug 20260 · 8
Sean Clinton Freeman Company insiderEVP, Strategy & Corp Devt · last 2 Jul 20260 · 1
Marc Wade Rosenbaum Company insiderChief Accounting Officer · last 2 Jun 20260 · 8
Abhijit Y. Talwalkar Company insiderDirector · last 27 May 20262 · 4
Brian B. Yoor Company insiderDirector · last 27 May 20260 · 0

Same industry

RCEL Avita MedicalLeading+108%
HTFL HeartflowLeading+59%
ATRC AtriCureLeading+52%
HAE HaemoneticsLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202570.6%
Operating profit marginFY 2025 · to 31 Dec 2025-7.7%
Free cash flow marginFY 2025 · to 31 Dec 20254.6%
Return on capital employedFY 2025 · to 31 Dec 2025-6.6%
Share count trendFY 2025 · to 12 Feb 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$236.0M
Free cash flowFY 2025 · to 31 Dec 2025$34.5M

Analyst forecasts

No analyst forecasts yet.